Becton, Dickinson and Company
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Becton, Dickinson and Company
BD has EUA for Veritor At-Home COVID-19 rapid antigen test using smartphone vision technology to interpret and digitally display results. Researchers at biotech firms and medical schools measure advantages of at-home use of rapid antigen tests over quantitative real-time polymerase chain reaction tests.
Increased demand tied to COVID-19, plus supply chain difficulties, led to the blood collection device shortage, the US agency says.
Patients who receive breast reconstructive surgery using some brands of acellular dermal matrix seem to have a higher risk of major complications than those whose surgeries did not use the mesh, says a safety alert from the US FDA.
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.